Literature DB >> 1920171

Cardiac failure: symptoms and functional status.

R Mayou1, R Blackwood, B Bryant, J Garnham.   

Abstract

The associations between exercise capacity, symptoms and specific aspects of quality of life were examined in subjects participating in a trial of the treatment of heart failure. Patients were assessed on entry and after three months treatment. The principle symptoms were fatigue, breathlessness and chest pain. These limited the extent and speed of physical activities, restricted social, leisure and family life and were associated with emotional distress. There were associations between baseline exercise capacity and measures of quality of life. Change in exercise capacity during three months treatment was correlated with changes in measures of symptoms, limitation of activity and quality of life. The findings confirm the value of change in exercise capacity as a measure of functional status and suggest that it should be supported by a limited number of specific measures of quality of life.

Entities:  

Mesh:

Year:  1991        PMID: 1920171     DOI: 10.1016/0022-3999(91)90035-m

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  15 in total

1.  Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey.

Authors:  Sheri L Maddigan; David H Feeny; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

2.  The influence of decisions made by developers on health status questionnaire content.

Authors:  C J O'Leary; P W Jones
Journal:  Qual Life Res       Date:  1998-08       Impact factor: 4.147

3.  Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial.

Authors:  I Wiklund; F Waagstein; K Swedberg; A Hjalmarsson
Journal:  Cardiovasc Drugs Ther       Date:  1996-07       Impact factor: 3.727

4.  Psychometric properties of three instruments to measure fatigue with myocardial infarction.

Authors:  Anne M Fink; Ann L Eckhardt; Michelle M Fennessy; Jessica Jones; Donna Kruse; Kathryn J VanderZwan; Catherine J Ryan; Julie J Zerwic
Journal:  West J Nurs Res       Date:  2010-08-04       Impact factor: 1.967

Review 5.  Neurocognitive Disorders in Heart Failure: Novel Pathophysiological Mechanisms Underpinning Memory Loss and Learning Impairment.

Authors:  C Toledo; D C Andrade; H S Díaz; N C Inestrosa; R Del Rio
Journal:  Mol Neurobiol       Date:  2019-06-05       Impact factor: 5.590

6.  Fatigue with systolic heart failure.

Authors:  Anne M Fink; Shawna L Sullivan; Julie J Zerwic; Mariann R Piano
Journal:  J Cardiovasc Nurs       Date:  2009 Sep-Oct       Impact factor: 2.083

7.  Relationships between fatigue and early postoperative recovery outcomes over time in elderly patients undergoing coronary artery bypass graft surgery.

Authors:  Susan Barnason; Lani Zimmerman; Janet Nieveen; Paula Schulz; Connie Miller; Melody Hertzog; Doris Rasmussen
Journal:  Heart Lung       Date:  2008 Jul-Aug       Impact factor: 2.210

8.  Sleep Disturbance, Daytime Symptoms, and Functional Performance in Patients With Stable Heart Failure: A Mediation Analysis.

Authors:  Sangchoon Jeon; Nancy S Redeker
Journal:  Nurs Res       Date:  2016 Jul-Aug       Impact factor: 2.381

9.  The influence of exercise tolerance on quality of life among patients with heart failure.

Authors:  Chii Jeng; Mei-Hsing Yang; Pao-Lo Chen; Chiung-Hua Ho
Journal:  Qual Life Res       Date:  2004-06       Impact factor: 4.147

10.  Effects of 12 weeks of ramipril treatment on the quality of life in patients with moderate congestive heart failure: results of a placebo-controlled trial. Ramipril Study Group.

Authors:  T Gundersen; I Wiklund; K Swedberg; O Amtorp; J Remes; B Nilsson
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.